"Letter regarding the article, “A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”." Drug Design, Development and Therapy, , pp. 385–386
Disclosure
The authors report no conflicts of interest in this communication.